Source: International Congress 2014 – Latest insights in airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. M. Mackay, C. Grainge, L. Lau, C. Barber, H. Clark, P. Howarth (southampton, United Kingdom; Newcastle, Australia). LATE-BREAKING ABSTRACT: Surfactant protein D is dysregulated in severe asthma. Eur Respir J 2014; 44: Suppl. 58, 2824

Member's Comments

No comment yet.

Related content which might interest you: Blood cytotoxic/pro-inflammatory mediators in severe asthma Source: International Congress 2014 – TH17 and other acute asthmatic responses Year: 2014 LATE-BREAKING ABSTRACT: Critical role of proton-sensing OGR1 in dendritic cells in development of asthma Source: International Congress 2014 – New technologies and biomarkers in lung disease Year: 2014 LATE-BREAKING ABSTRACT: The effect of temperature during sputum processing on inflammatory markers Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 LATE-BREAKING ABSTRACT: The CCR4 Antagonist CCX6239 for the treatment of allergic airways disease Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Vitamin D levels and bronchial obstruction in childhood Source: International Congress 2014 – More paediatric asthma Year: 2014 Investigating airway HMGB1 redox state in health and asthma Source: International Congress 2014 – Allergy and asthma: novel findings based on human cell biology Year: 2014 Vitamin D status and lung function in children with asthma Source: International Congress 2014 – More paediatric asthma Year: 2014 Proteins regulating iron metabolism in asthmatic children Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Fungal sensitization in patients with moderate and severe asthma Source: International Congress 2014 – Clinical allergy Year: 2014 Altered airway microbiome in stable asthma Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 LATE-BREAKING ABSTRACT: Phosphoinositide-dependent protein kinase-1 mediates inhibitory effects on eosinophils. Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 LATE-BREAKING ABSTRACT: A phase 2 study of benralizumab on exacerbations, lung function, and asthma control in adults with uncontrolled eosinophilic asthma Source: International Congress 2014 – The future has started: emerging potentials for personalised asthma treatment Year: 2014 Investigating the role of BAFF in murine models of allergic asthma Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 Autoreactivity in patients with combined COPD and asthma phenotype Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma Year: 2014 Allergic and non-allergic childhood asthma is characterized by novel biomarkers and signaling pathways Source: International Congress 2014 – Paediatric asthma: markers and molecules Year: 2014 LATE-BREAKING ABSTRACT: BAFF: a self-perpetuating mechanism of B cell activation in COPD Source: International Congress 2014 – COPD physiopathology Year: 2014 Serum vitamin D levels In patients with asthma Source: International Congress 2014 – Biomarkers of asthma and clinical immunology Year: 2014 LATE-BREAKING ABSTRACT: Using eosinophilic phenotype to characterize asthma control. Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Genetic polymorphisms in early and late-onset bronchial asthma Source: International Congress 2014 – Asthma: clinical problems Year: 2014 LATE-BREAKING ABSTRACT: Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015